Precision Cirrhosis

What is Precision Cirrhosis?

Opportunistic screening for cirrhosis and steatotic liver disease from the subcostal view captured during routine echocardiography. Applies deep learning to the subcostal echo view to screen for cirrhosis and steatotic liver disease — no additional imaging or patient time required. Built on the EchoNet-Liver pipeline, developed from over 1.5 million echocardiogram videos and validated against paired abdominal ultrasound and MRI studies at two large academic medical centers. In development; an AHA-funded prospective multi-center validation trial is underway.

What teams use Precision Cirrhosis for

Integrations and access

Platforms, integrations, and language support vary by plan and region. Confirm final requirements with the vendor.

What reviewers say

Enterprise readiness

Compliance claims are normalized from current vendor documentation and independently reviewed by SOTA2.

SOC 2

ISO 9001

HIPAA

FDA 510(k) Clearance — Precision LVEF

FDA 510(k) Clearance — Precision Cardiac Amyloid

FDA Breakthrough Device Designation — Precision Cardiac Amyloid

FDA Breakthrough Device Designation — Precision Cirrhosis

FDA Total Product Lifecycle Advisory Program (TAP) — Precision Cardiac Amyloid

CPT Category III code 0932T (effective January 1, 2025) — Precision Cardiac Amyloid

DICOM Part 15 compliance — Automatic DICOM Deidentification

Benchmarks and comparisons

Alternatives to Precision Cirrhosis

ImagingHandheld intraoral scanner using advanced OCT technology to capture 3D volumetric data including below the gum line, through fluids, and under the tooth surface, without ionizin...0.00 reviewsDiagnostics & Imaging

Referral PortalSeamless study sharing and incoming orders between referring physicians and imaging centers.0.00 reviewsDiagnostics & Imaging

DovaVision BEAI-powered real-time Barrett's Esophagus surveillance and early esophageal adenocarcinoma (EAC) detection.0.00 reviewsDiagnostics & Imaging